Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000482

Director sold 171,000 shares at an average $13.51 ($2,310,420)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ORBIMED ADVISORS LLC Director 2018-05-30 Sale −121,000 $13.52 $1,635,920 4,970,010 I
ORBIMED ADVISORS LLC Director 2018-06-01 Sale −50,000 $13.49 $674,500 4,920,010 I
Open-market sales · 171,000 sh · avg $13.51 · $2,310,420
Loading xslF345X03/ss94361_4.xml…